scholarly journals Predictive Analytics for Caring and Managing Acute Disease Patients: A Deep Learning–Based Method to Predict Crucial Complications Phenotypes (Preprint)

2020 ◽  
Author(s):  
Jessica Qiuhua Sheng ◽  
Paul Jen-Hwa Hu ◽  
Xiao Liu ◽  
Ting-Shuo Huang ◽  
Yu-Hsien Chen

BACKGROUND Acute diseases have severe complications that develop rapidly, exhibit distinct phenotypes, and have profound effects on patient outcomes. Predictive analytics can enhance physicians’ care and management of acute disease patients by predicting crucial complication phenotypes for timely diagnosis and treatment. However, effective phenotype predictions require overcoming several challenges. First, patient data collected in the early stages of an acute disease (e.g., clinical data, laboratory results) are less informative for predicting phenotypic outcomes. Second, patient data are temporal and heterogeneous; for example, patients receive laboratory tests at different time intervals and frequencies. Third, imbalanced distributions of patient outcomes create an additional complexity for complication phenotype predictions. OBJECTIVE To predict crucial complication phenotypes among patients suffering acute diseases, we propose a novel, deep learning–based method that uses recurrent neural network–based sequence embedding to represent disease progressions, with the consideration of temporal heterogeneities in patient data. Our method incorporates a latent regulator to alleviate data insufficiency constraints by accounting for the underlying mechanisms that are not observed in patient data. The proposed method also includes cost-sensitive learning to address imbalanced outcome distributions in patient data for improved predictions. METHODS From a major health care organization in Taiwan, we obtain a sample of 10,354 electronic health records that pertain to 6,545 peritonitis patients. The proposed method projects these temporal, heterogeneous, clinical data into a substantially reduced feature space, then incorporates a latent regulator (latent parameter matrix) to obviate data insufficiencies and account for variations in phenotypic expressions. In addition, our method employs cost-sensitive learning to increase predictive performance further. RESULTS We evaluate the proposed method’s efficacy for predicting two hepatic complication phenotypes for peritonitis patients: acute hepatic encephalopathy (A-HE) and hepatorenal syndrome (HRS). The evaluation includes three benchmark techniques: temporal case-based reasoning (T-MMCBR), temporal short long-term memory (T-SLTM) networks, and time fusion convolutional neural network (CNN). For A-HE predictions, our method attains an area under the curve (AUC) of 0.82, which outperforms T-MMCBR by 64%, T-SLTM by 26%, and time fusion CNN by 26%. For HRS predictions, our method achieves an AUC of 0.64, which is 29% better than that of T-MMCBR (0.54). Overall, the evaluation results show that the proposed method significantly outperforms all the benchmarks, as measured by recall, F-measure, and AUC, while maintaining comparable precision values. CONCLUSIONS The proposed method learns a short-term temporal representation from patient data to predict complication phenotypes, and it offers greater predictive utilities than prevalent data-driven techniques. This method is generalizable and can be applied to different acute disease (illness) scenarios that are characterized by insufficient patient clinical data availability, temporal heterogeneities, and imbalanced distributions of important patient outcomes. CLINICALTRIAL

Author(s):  
A John. ◽  
D. Praveen Dominic ◽  
M. Adimoolam ◽  
N. M. Balamurugan

Background:: Predictive analytics has a multiplicity of statistical schemes from predictive modelling, data mining, machine learning. It scrutinizes present and chronological data to make predictions about expectations or if not unexplained measures. Most predictive models are used for business analytics to overcome loses and profit gaining. Predictive analytics is used to exploit the pattern in old and historical data. Objective: People used to follow some strategies for predicting stock value to invest in the more profit-gaining stocks and those strategies to search the stock market prices which are incorporated in some intelligent methods and tools. Such strategies will increase the investor’s profits and also minimize their risks. So prediction plays a vital role in stock market gaining and is also a very intricate and challenging process. Method: The proposed optimized strategies are the Deep Neural Network with Stochastic Gradient for stock prediction. The Neural Network is trained using Back-propagation neural networks algorithm and stochastic gradient descent algorithm as optimal strategies. Results: The experiment is conducted for stock market price prediction using python language with the visual package. In this experiment RELIANCE.NS, TATAMOTORS.NS, and TATAGLOBAL.NS dataset are taken as input dataset and it is downloaded from National Stock Exchange site. The artificial neural network component including Deep Learning model is most effective for more than 100,000 data points to train this model. This proposed model is developed on daily prices of stock market price to understand how to build model with better performance than existing national exchange method.


Stroke ◽  
2020 ◽  
Vol 51 (11) ◽  
pp. 3361-3365 ◽  
Author(s):  
Fareshte Erani ◽  
Nadezhda Zolotova ◽  
Benjamin Vanderschelden ◽  
Nima Khoshab ◽  
Hagop Sarian ◽  
...  

Background and Purpose: Clinical methods have incomplete diagnostic value for early diagnosis of acute stroke and large vessel occlusion (LVO). Electroencephalography is rapidly sensitive to brain ischemia. This study examined the diagnostic utility of electroencephalography for acute stroke/transient ischemic attack (TIA) and for LVO. Methods: Patients (n=100) with suspected acute stroke in an emergency department underwent clinical exam then electroencephalography using a dry-electrode system. Four models classified patients, first as acute stroke/TIA or not, then as acute stroke with LVO or not: (1) clinical data, (2) electroencephalography data, (3) clinical+electroencephalography data using logistic regression, and (4) clinical+electroencephalography data using a deep learning neural network. Each model used a training set of 60 randomly selected patients, then was validated in an independent cohort of 40 new patients. Results: Of 100 patients, 63 had a stroke (43 ischemic/7 hemorrhagic) or TIA (13). For classifying patients as stroke/TIA or not, the clinical data model had area under the curve=62.3, whereas clinical+electroencephalography using deep learning neural network model had area under the curve=87.8. Results were comparable for classifying patients as stroke with LVO or not. Conclusions: Adding electroencephalography data to clinical measures improves diagnosis of acute stroke/TIA and of acute stroke with LVO. Rapid acquisition of dry-lead electroencephalography is feasible in the emergency department and merits prehospital evaluation.


2021 ◽  
Author(s):  
Siting Goh ◽  
Yueda Chua ◽  
Justina Lee ◽  
Joe Yeong ◽  
Yiyu Cai

Recent advancements in deep learning based artificial intelligence have enabled us to analyse complex data in order to provide patients with improved cancer prognosis, which is an important goal in precision health medicine. In this chapter, we would be discussing how deep learning could be applied to clinical data and immunopathological images to accurately determine survival rate prediction for patients. Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) is a relatively new technology for simultaneous detection of multiple specific proteins from a single tissue section. To adopt deep learning, we collected and pre-processed the clinical and mIHC/IF data from a group of patients into three branches of data. These data were subsequently used to train and validate a neural network. The specific process and our recommendations will be further discussed in this chapter. We believe that our work will help the community to better handle their data for AI implementation while improving its performance and accuracy.


10.2196/24973 ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. e24973
Author(s):  
Thao Thi Ho ◽  
Jongmin Park ◽  
Taewoo Kim ◽  
Byunggeon Park ◽  
Jaehee Lee ◽  
...  

Background Many COVID-19 patients rapidly progress to respiratory failure with a broad range of severities. Identification of high-risk cases is critical for early intervention. Objective The aim of this study is to develop deep learning models that can rapidly identify high-risk COVID-19 patients based on computed tomography (CT) images and clinical data. Methods We analyzed 297 COVID-19 patients from five hospitals in Daegu, South Korea. A mixed artificial convolutional neural network (ACNN) model, combining an artificial neural network for clinical data and a convolutional neural network for 3D CT imaging data, was developed to classify these cases as either high risk of severe progression (ie, event) or low risk (ie, event-free). Results Using the mixed ACNN model, we were able to obtain high classification performance using novel coronavirus pneumonia lesion images (ie, 93.9% accuracy, 80.8% sensitivity, 96.9% specificity, and 0.916 area under the curve [AUC] score) and lung segmentation images (ie, 94.3% accuracy, 74.7% sensitivity, 95.9% specificity, and 0.928 AUC score) for event versus event-free groups. Conclusions Our study successfully differentiated high-risk cases among COVID-19 patients using imaging and clinical features. The developed model can be used as a predictive tool for interventions in aggressive therapies.


2020 ◽  
Author(s):  
Sanghun Choi ◽  
Jae-Kwang Lim ◽  
Thao Thi Ho ◽  
Jongmin Park ◽  
Taewoo Kim ◽  
...  

BACKGROUND Many COVID-19 patients rapidly progress into respiratory failure with a broad range of severity. Identification of the high-risk cases is critical for early intervention. OBJECTIVE The aim of this study is to develop deep learning models that can rapidly diagnose high-risk COVID-19 patients based on computed tomography (CT) images and clinical data. METHODS We analyzed 297 COVID-19 patients from five hospitals in Daegu, South Korea. A mixed model (ACNN) including an artificial neural network for clinical data and a convolution-neural network for 3D CT imaging data is developed to classify high-risk cases with a severe progression (event) from low-risk COVID-19 patients (event-free). RESULTS By using the mixed ACNN model, we could obtain high classification performance using novel coronavirus pneumonia (NCP) lesion images (93.9% accuracy, 80.8% sensitivity, 96.9% specificity, and 0.916 AUC) and using lung segmentation images (94.3% accuracy, 74.7% sensitivity, 95.9% specificity, and 0.928 AUC) for event vs. event-free groups. CONCLUSIONS Our study has successfully differentiated high-risk cases among COVID-19 patients using the imaging and clinical features of COVID-19 patients. The developed model is potentially utilized as a prediction tool for intervening active therapy.


2016 ◽  
Author(s):  
Saman Sarraf ◽  
Ghassem Tofighi

Over the past decade, machine learning techniques and in particular predictive modeling and pattern recognition in biomedical sciences, from drug delivery systems to medical imaging, have become one of the most important methods of assisting researchers in gaining a deeper understanding of issues in their entirety and solving complex medical problems. Deep learning is a powerful machine learning algorithm in classification that extracts low- to high-level features. In this paper, we employ a convolutional neural network to distinguish an Alzheimer′s brain from a normal, healthy brain. The importance of classifying this type of medical data lies in its potential to develop a predictive model or system in order to recognize the symptoms of Alzheimer′s disease when compared with normal subjects and to estimate the stages of the disease. Classification of clinical data for medical conditions such as Alzheimer′s disease has always been challenging, and the most problematic aspect has always been selecting the strongest discriminative features. Using the Convolutional Neural Network (CNN) and the famous architecture LeNet-5, we successfully classified functional MRI data of Alzheimer′s subjects from normal controls, where the accuracy of testing data reached 96.85%. This experiment suggests that the shift and scale invariant features extracted by CNN followed by deep learning classification represents the most powerful method of distinguishing clinical data from healthy data in fMRI. This approach also allows for expansion of the methodology to predict more complicated systems.


2019 ◽  
Author(s):  
Rafik Margaryan ◽  
Daniele Della Latta ◽  
Giacomo Bianchi ◽  
Nicola Martini ◽  
Gianmarco Santini ◽  
...  

AbstractObjectiveAbout 10 million people in Europe suffer from mitral valve incompetence. Majority of these entity is mitral valve prolapse in developed countries. Endoscopic mitral valve surgery is a relatively new procedure and preparation in the right intercostal space are crucial for success completion of the procedure. We aimed to explore clinical variables and chest X-rays in order to build most performant model that can predict the right intercostal space for thoracotomy.MethodsOverall 234 patients underwent fully endoscopic mitral valve surgery. All patients had preoperative two projection radiography. Intercostal space for right thoracotomy was decided by expert cardiac surgeons taking in consideration the height, weight, chest radiography, anatomical position of skin incision, nipple position and the sex. In order to predict the right intercostal space we have used clinical data and we have collected all radiographies and feed it to deep neural network algorithm. We have spitted the whole data-set into two subsets: training and testing data-sets. We have used clinical data and build an algorithm (Random Forest) in order to have reference model.ResultsThe best-performing classifier was GoogLeNet neural network (now on we will reffera as Deep Learning) and had an AUC of 0.956. Algorithm based on clinical data (Random Forest) had AUC of 0.529 using only chest x-rays. The deep leaning algorithm predicted correctly in all cases the correct intercostal space on the training datasest except two ladies (96.08% ; with sensitivity of 97.06% and specificity 94.12 %, where the Random Forest was capable to predict right intercostal space in 60.78% cases with sensitivity of 93.33% and specificity 14.29 % (only clinical data).ConclusionArtificial intelligence can be helpful to program the minimally invasive cardiac operation, for right intercostal space selection for thoracotomy, especially in non optimal thoraxes (example, obese short ladies). It learned from the standard imaging (thorax x-ray) which is easy, do routinely to every patient.


2020 ◽  
Vol 2 ◽  
pp. 58-61 ◽  
Author(s):  
Syed Junaid ◽  
Asad Saeed ◽  
Zeili Yang ◽  
Thomas Micic ◽  
Rajesh Botchu

The advances in deep learning algorithms, exponential computing power, and availability of digital patient data like never before have led to the wave of interest and investment in artificial intelligence in health care. No radiology conference is complete without a substantial dedication to AI. Many radiology departments are keen to get involved but are unsure of where and how to begin. This short article provides a simple road map to aid departments to get involved with the technology, demystify key concepts, and pique an interest in the field. We have broken down the journey into seven steps; problem, team, data, kit, neural network, validation, and governance.


Sign in / Sign up

Export Citation Format

Share Document